Key Takeaways for Procter & Gamble Stock as of July 2026
- Fifteen of the 26 analysts covering Procter & Gamble stock rate it buy or outperform, ten rate it hold, and none carry a sell, with the mean target of $163 sitting 11% above the July 10 close of $147.
- TIKR’s mid-case model targets Procter & Gamble stock at $202 by mid-2030, a 37% total return worth 8% annualized.
- Normalized EPS is set to fall 4% year-over-year this fiscal fourth quarter before reaccelerating to 8% growth by June 2027, a swing that leaves Procter & Gamble stock priced closer to the trough than the recovery.
- Procter & Gamble reports fiscal fourth-quarter results on July 29, 2026.
Procter & Gamble Stock Faces a $1 Billion Oil Shock Just Before Q4 Earnings
Procter & Gamble (PG) sells household staples across ten categories, from Tide detergent to Pampers diapers to SK-II skincare, and its fiscal third-quarter results showed organic sales up more than 3% with normalized EPS of $1.59, up 3% year over year. That growth came with a catch buried in the guidance.
CFO Andre Schulten addressed it directly on the Q3 earnings call, tying the pressure to the conflict in the Middle East: “We now expect a headwind of approximately $150 million after tax for the fiscal from a combination of commodity-linked cost inflation, feedstock exposures and logistics disruptions.” He later quantified the fuller annual exposure at close to $1 billion after tax if Brent crude holds near $100 a barrel, versus a pre-conflict price in the mid-$60s.
Nearly all of that cost lands in the fiscal fourth quarter, the one Procter & Gamble will report on July 29, 2026, via webcast at 8:30 a.m. ET. Guidance already points to the low end of the $6.83 to $7.09 core EPS range for the year.
Beneath the cost story, the underlying business kept moving. Baby Care returned to global share growth, SK-II sales in China jumped 18%, and the company is cutting up to 7,000 non-manufacturing roles as part of a two-year restructuring aimed at $2.0 billion to $2.2 billion in productivity savings. Procter & Gamble also extended its dividend streak to 70 consecutive annual increases, the 136th straight year of payment, a record few consumer staples names can match.
Procter & Gamble stock trades near $147 heading into that print. Investors are about to learn how much of the oil-driven hit already showed up and how much is still coming.
Wall Street Rates Procter & Gamble Stock a Buy With Limited Downside Protection
Wall Street’s consensus on Procter & Gamble stock leans bullish, with 15 of 26 covering analysts rating it buy or outperform, 10 at hold, and zero sell or underperform ratings as of July 10, 2026. The mean price target of $163 sits 11% above the current price of $147, a gap that has narrowed steadily from a $173 mean target back in June 2025.
That decline in the target price ran alongside a $1 billion cost headwind building through the same period, even as none of the 23 analysts supplying price targets moved to a sell rating.
Wall Street Expects Procter & Gamble Stock’s Normalized EPS to Swing From a Decline to 8% Growth
Procter & Gamble stock’s normalized EPS came in at $1.59 for the quarter ended March 31, 2026, up 3% year over year and ahead of the prior two quarters’ deceleration. The current fiscal fourth quarter, ending June 30, 2026, is expected to reverse that trend, with normalized EPS falling to $1.42, a 4% decline tied directly to the oil-driven cost spike.
That pressure persists into the first quarter of fiscal 2027, with normalized EPS estimated at $1.94, still down 3% against a tough prior-year comparison. From there, the trajectory turns. Normalized EPS is projected to grow 3% by March 2027 and accelerate to 8% growth by June 2027, reaching $1.54.
The July 29 print will show whether the trough has already been reached or whether the Middle East cost exposure runs deeper into fiscal 2027 than current estimates assume.
TIKR’s $202 Target on Procter & Gamble Stock Holds if the EPS Reacceleration Arrives on Schedule
TIKR’s mid-case model values Procter & Gamble stock at $202 by June 2030, a 37% total return from the current price of $147, or 8% annualized over the next four years.
That annualized rate lands in line with long-run equity market returns, a reasonable outcome for a stock carrying a five-year beta of just 0.40 and a float above 99%. The target is reachable if the productivity program funds the offset to oil-driven costs the way CFO Andre Schulten described, letting normalized EPS growth climb from a 4% decline this quarter back to 8% growth by June 2027 without Procter & Gamble stock sacrificing the demand-creation spending behind Baby Care and SK-II.
Should You Invest in The Procter & Gamble Company?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up The Procter & Gamble Company stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track The Procter & Gamble Company alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Access Professional Tools to Analyze PG stock on TIKR for Free →
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
